TITLE

DELAYS IN PRESENTATION AND DIAGNOSIS OF PATIENTS WITH OESOPHAGEAL AND GASTRIC CANCER IN SCOTLAND

PUB. DATE
April 2004
SOURCE
Gut;Apr2004 Supplement 3, Vol. 53, pA115
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Delays in presentation of symptoms, attaining diagnosis, and initiation of treatment may adversely affect outcome in patients with oesophageal and gastric cancer. This article cites a study conducted to identify contributory factors to such delays. Results of the study suggest that community based education and guidelines have been introduced to heighten patient awareness of upper gastrointestinal symptoms. However a greater impact in facilitating a rapid diagnosis, thereby reducing target times to treatment, may be achieved by minimising system delays in the processing of patients with oesophageal and gastric cancers.
ACCESSION #
13219263

 

Related Articles

  • The Economic Impact of the Diagnosis of Dysplasia in Barrett's Esophagus. Ofman, Joshua J.; Lewin, Klaus; Ramers, Christian; Ippoliti, Andy; Lieberman, David; Weinstein, Wilfred // American Journal of Gastroenterology;Oct2000, Vol. 95 Issue 10, p2946 

    OBJECTIVE: Cost-effective strategies for identifying patients with Barrett's esophagus who are most likely to develop cancer have not been developed. Surveillance endoscopy is currently used, and we hypothesized that more frequent surveillance intervals would identify patients with "transient...

  • Pre-therapy mRNA expression of TNF is associated with regimen-related gastrointestinal toxicity in patients with esophageal cancer: a pilot study. Bowen, J.; White, I.; Smith, L.; Tsykin, A.; Kristaly, K.; Thompson, S.; Karapetis, C.; Tan, H.; Game, P.; Irvine, T.; Hussey, D.; Watson, D.; Keefe, D.; Bowen, J M; Thompson, S K; Karapetis, C S; Game, P A; Hussey, D J; Watson, D I; Keefe, D M K // Supportive Care in Cancer;Nov2015, Vol. 23 Issue 11, p3165 

    Purpose: Esophageal cancer has a high mortality rate, and its multimodality treatment is often associated with significant rates of severe toxicity. Effort is needed to uncover ways to maximize effectiveness of therapy through identification of predictive markers of response and...

  • Prognostic Value of E-Cadherin, β-Catenin, CD44v6, and HER2/neu in Metastatic Cutaneous Adenocarcinoma. Pozdnyakova, Olga; Mai M. P. Hoang; Dresser, Karen A.; Mahalingam, Meera // Archives of Pathology & Laboratory Medicine;Aug2009, Vol. 133 Issue 8, p1285 

    Context.—Our recent experience with a patient developing cutaneous metastases within 3 months of diagnosis of esophageal adenocarcinoma suggests that altered expression of the cellular adhesion molecules, E-cadherin and CD44v6, may have had a role to play in the rapid onset of metastases....

  • BARRETT'S OESOPHAGUS IS AN INDEPENDENT RISK FACTOR IN TUMOURS OF THE UPPER GASTROINTESTINAL TRACT. Li, A.G.K.; Fernandex, E.; Baird, J.; Park, K.G.M. // Gut;Apr2003 Supplement 1, Vol. 52, pA48 

    Background: Epidemiological studies suggest that Barrett's specialised intestinal metaplasia (SIM) is a pre-malignant precursor for adeno-carcinomas of the oesophagus (OAC) and oesophago-gastric junction (OGJ). Surveillance programmes are currently based on the stringent endoscopic biopsy of all...

  • Survival with Carcinoma of the Esophagus. Lowe, William C. // Annals of Internal Medicine;Dec72, Vol. 77 Issue 6, p915 

    Focuses on the histologic diagnosis of patients with squamous cell carcinoma of the esophagus. Definition of epidermoid carcinoma of the esophagus; Different modalities of treatment for patients with carcinoma; Percentage of survival of patients who received resectional surgery.

  • Screening for oesophageal neoplasia in patients with head and neck cancer. Scherubl, H.; von Lampe, B. // British Journal of Cancer;1/21/2002, Vol. 86 Issue 2, p239 

    Due to advanced disease at the time of diagnosis the prognosis of oesophageal cancer is generally poor. As mass screening for oesophageal cancer is neither feasible nor reasonable, high-risk groups should be identified and surveilled. The aim of this study was to define the risk of oesophageal...

  • Secondary Primary Malignancy Risk among Patients with Esophageal Cancer in Taiwan: A Nationwide Population-Based Study. Chen, San-Chi; Teng, Chung-Jen; Hu, Yu-Wen; Yeh, Chiu-Mei; Hung, Man-Hsin; Hu, Li-Yu; Ku, Fan-Chen; Tzeng, Cheng-Hwai; Chiou, Tzeon-Jye; Chen, Tzeng-Ji; Liu, Chia-Jen // PLoS ONE;Jan2015, Vol. 10 Issue 1, p1 

    Background: To evaluate the risk and sites of metachronous secondary primary malignancies (SPMs) among patients with esophageal cancer. Methods: Newly diagnosed esophageal cancer patients between 1997 and 2011 were recruited. To avoid surveillance bias, SPMs that developed within one year were...

  • THE ACCURACY OF EUS, HCT AND PET IN RE-STAGING OF OESOPHAGEAL CANCER FOLLOWING CHEMOTHERAPY. Meenan, J.; Rankin, S.; Marx, G.; Harper, P. // Gut;Apr2003 Supplement 1, Vol. 52, pA31 

    The best approach to re-staging oesophageal cancer following chemotherapy is unknown. Potential limitations exist for all imaging modalities: hCT and EUS cannot differentiate between viable tumour and inflammation, whereas although PET scanning may detect remnant malignancy, it lacks spatial...

  • Reduced expression of Axin correlates with tumour progression of oesophageal squamous cell carcinoma. Nakajima, M; Fukuchi, M; Miyazaki, T; Masuda, N; Kato, H; Kuwano, H // British Journal of Cancer;6/2/2003, Vol. 88 Issue 11, p1734 

    Axin is a negative regulator of the Wnt signalling pathway, and genetic alterations of AXIN1 have been suggested to be an important factor of carcinogenesis in some tumours. The objective of this study was to clarify the clinicopathologic and prognostic significance of Axin in oesophageal...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics